Skip to main content

Table 1 Patients characteristics of this study

From: Three-tube method and covered metallic stent for the treatment of anastomotic leakage after esophagectomy

No.

Gender

Age (years)

Cause

Course of disease (Months)

Duration from surgery to leakage (Days)

Fistula type

Size (mm)

Location of fistula

Comorbidities

Pleural effusion

Atelectasis

Stent size ×

Complications

1

Male

61

Esophageal cancer

1.5

9

Gastroesophageal anastomotic fistula

2.9

Lower part

None

A small amount

None

20 × 120

Stent migration

2

Male

52

Esophagogastric carcinoma

0.6

12

Gastroesophageal anastomotic fistula

6.5

Middle part

None

None

None

20 × 130;20 × 100

None

3

Male

68

Esophageal cancer

0.8

6

Gastroesophageal anastomotic fistula

7.0

Middle part

None

A small amount

None

20 × 70

Stent migration

4

Male

65

Carcinoma of gastric cardia

2.0

60

Gastroesophageal anastomotic fistula

8.0

Upper and middle parts

Esophageal stricture+coronary heart disease

None

None

20 × 120;20 × 120

Stent restenosis

5

Male

70

Carcinoma of gastric cardia

1.0

12

Gastroesophageal anastomotic fistula

8.4

Middle part

None

None

None

20 × 120

None

6

Male

53

Carcinoma of gastric cardia

2.0

150

Gastroesophageal anastomotic fistula

2.1

Middle part

Esophageal stricture

A small amount

None

20 × 120;18 × 160;18 × 120

Stent restenosis

7

Male

70

Esophageal cancer

6.0

171

Gastroesophageal anastomotic fistula

9.5

Middle part

Hypetension+Diabetes

None

Mild

18 × 120

None

8

Male

63

Gastric carcinoma

4.0

36

Anastomotic leak after esophagojejunostomy

4.8

Lower part

Esophageal stricture

None

None

20 × 100;20 × 100

Stent restenosis

9

Male

50

Esophagogastric carcinoma

3.0

30

Gastroesophageal anastomotic fistula

1.3

Lower part

Hypetension

A small amount

Moderate

18 × 100

None

10

Male

76

Esophageal cancer

1.0

6

Gastroesophageal anastomotic fistula

1.8

Middle part

Diabetes

None

None

18 × 120;18 × 120

Stent migration

11

Male

53

Gastric carcinoma

6.0

9

Anastomotic leak after esophagojejunostomy

5.1

Lower part

None

None

None

20 × 100

None

12

Male

58

Esophageal cancer

3.0

6

Gastroesophageal anastomotic fistula

5.5

Middle part

None

A small amount

Mild

18 × 120

None

13

Male

64

Carcinoma of gastric cardia

3.0

6

Anastomotic leak after esophagojejunostomy

9.6

Lower part

None

A small amount

Mild

20 × 100–20 × 40–20 × 40

None

14

Male

52

Esophageal perforation

4.0

12

Gastroesophageal anastomotic fistula

5.1

Lower part

None

Medium

Moderate

20 × 120

None

15

Male

58

Esophageal cancer

0.5

9

Gastroesophageal anastomotic fistula

8.8

Upper and middle parts

Diabetes

A small amount

None

20 × 80

Stent migration

16

Male

52

Esophageal cancer

5.0

15

Gastroesophageal anastomotic fistula

7.1

Middle part

None

A small amount

Mild

18 × 90

Stent migration

17

Male

60

Esophageal cancer

3.0

9

Gastroesophageal anastomotic fistula

9.3

Middle part

None

None

None

18 × 100

Stent migration

18

Female

51

Gastric carcinoma

11.0

270

Anastomotic leak after esophagojejunostomy

7.6

Lower part

Esophageal stricture

None

None

22 × 80–22 × 50–22 × 50

Failure in stent placement

19

Male

43

Carcinoma of gastric cardia

3.0

69

Anastomotic leak after esophagojejunostomy

6.7

Lower part

Esophageal stricture

Medium

Moderate

20 × 120

Stent migration

20

Male

54

Esophageal cancer

1.0

210

Gastroesophageal anastomotic fistula

7.7

Middle and lower parts

None

A small amount

None

18 × 140;20 × 120

Migration of stent and abscess drainage tube

21

Female

72

Gastric carcinoma

0.3

6

Anastomotic leak after esophagojejunostomy

4.1

Lower part

None

None

None

20 × 100

None

22

Male

65

Carcinoma of gastric cardia

1.0

15

Gastroesophageal anastomotic fistula

5.9

Lower part

None

A small amount

Mild

20 × 120

None

23

Female

65

Gastric carcinoma

6.0

18

Anastomotic leak after esophagojejunostomy

3.8

Lower part

Diabetes

None

None

20 × 140

Stent migration

24

Male

59

Carcinoma of gastric cardia

12.0

12

Anastomotic leak after esophagojejunostomy

5.2

Lower part

None

Medium

Moderate

20 × 140

None

Adjustment/replacement time of stent

Adjustment/replacement time of abscess drainage tube

Abscess cavity

Removal of stent/abscess drainage tube

Retention of stent (Months)

Retention of drainage tube (Months)

Maximal body temperature (°C)

Leukocytes (×109/L)

Neutrophil (%)

Other interventional treatments

Survival time after procedure (M)

Death cause

  

1

1

Disappear

Yes

1.6

14.6

Normal

7.7

72.5

None

67.1

Survive without symptom

  

1

0

Disappear

Yes

1.5

2.1

Normal

4.5

64.9

None

24.5

Survive with slight reflux

  

3

2

Decreased

Yes

10.5

10.6

39.0

7.4

76.3

None

19.9

Survive without symptom

  

1

0

Decreased

No

1.8

1.4

38.5

8.7

62.7

Balloon dilation

6.6

Survive without symptom

  

0

3

Disappear

Yes

2.2

2.3

38.9

11.1

92.0

Balloon dilation

12.3

Survive without symptom

  

3

4

Disappear

Yes

3.2

5.9

38.6

12.8

88.2

Balloon dilation

17.3

Survive without symptom

  

0

0

Decreased

No

6.8

6.9

38.1

16.5

86.2

PTCD

6.9

Died of cancer recurrence

  

1

0

Disappear

No

1.0

1.0

Normal

3.9

45.4

None

6.8

Survive without symptom

  

0

0

Disappear

Yes

2.4

1.4

39.0

20.0

84.7

None

14.4

Survive without symptom

  

1

3

Disappear

No

6.0

2.2

Normal

6.0

85.2

None

6.0

Survive without symptom

  

0

4

Disappear

Yes

2.1

5.9

38.6

11.5

93.1

None

8.1

Died of cancer recurrence

  

0

0

Decreased

No

6.1

6.1

40.0

11.0

84.8

None

6.1

Died of cancer recurrence

  

0

2

Decreased

No

2.9

2.9

39.5

7.5

84.4

None

2.9

Died of cancer recurrence

  

0

2

Decreased

Yes

4.0

3.3

Normal

8.4

59.0

None

147.6

Survive without symptom

  

2

2

Disappear

Yes

8.4

11.4

Normal

17.6

94.2

None

23.9

Survive without symptom

  

3

0

Decreased

No

2.8

2.8

Normal

12.0

75.6

None

2.8

Died of pulmonary infection

  

3

0

Disappear

Yes

1.0

0.4

Normal

11.5

91.6

None

1.4

Died of cancer recurrence

  

0

2

Disappear

No

0.0

1.4

Normal

10.3

84.6

Balloon dilation

1.3

Died of cancer recurrence

  

1

2

Disappear

No

1.3

1.3

37.5

15.6

89.3

None

1.2

Died of pulmonary infection

  

2

3

Decreased

No

14.3

18.6

Normal

14.0

86.0

None

14.3

Survive, but the fistula wasn’t healed

  

0

2

Disappear

Yes

0.6

0.6

Normal

12.9

90.1

None

2.1

Died of cancer recurrence

  

0

6

Disappear

Yes

2.4

2.9

Normal

6.4

80.0

Bilateral ureteral stent implantation

7.6

Survive without symptom

  

1

0

Disappear

Yes

1.5

1.5

38.3

23.5

95.4

PTCD+stenting in colon

19.9

Died of cancer recurrence

  

0

0

Disappear

Yes

1.1

1.2

38.5

19.9

92.3

None

60.4

Survive without symptom

  
  1. PTCD percutaneous transhepatic cholangial drainage